u/Smooth_Earth_2948

​

Hey guys it's me again !

We talk a lot about classic tryptamines here, but there is a massive shift happening right now in clinical research. Big Pharma and top universities have figured out a chemical "hack" to take classic psychedelics and completely kill the visual/hallucinogenic trip, while keeping the therapeutic and social benefits.

The secret? Slapping a Fluorine (F) atom at the 4-position.

Here is a quick breakdown of how this works and why compounds like 4F-DMT and 4F-5-MeO-DMT are changing the game.

The Science: Why Fluorine kills the trip

In classic tryptamines (like 4-HO-DMT / psilocin), the "HO" (hydroxy) group acts like a perfect key. It forms a hydrogen bond with your 5-HT2A receptors, which is what triggers intense visuals and the classic psychedelic headspace.

However, Fluorine is physically incapable of forming that same hydrogen bond. So, by replacing the "HO" with an "F" at the 4-position, the molecule basically misses the 5-HT2A receptor. It neuters the visual magic. But instead of doing nothing, the molecule shifts its focus to other, very specific receptors.

1. 4F-DMT : Mild empathogen

When you put a Fluorine on classic DMT, it loses its ability to blast you into hyperspace. Instead, it heavily targets the 5-HT2C receptors.

The Effects: It completely shifts from a visual psychedelic into a short-acting, mild empathogen/entactogen.

Users describe it as a "social enhancer". You get practically zero headspace and no geometric patterns, just pure chatty energy, empathy, and good vibes. It’s essentially a mild "diet MDMA" perfect for hanging out with friends, without the nasty comedown or jaw clenching.

2. 4F-5-MeO-DMT : Antidepressant on steroids

This is where the medical world is putting its money. In May 2024, researchers at Mount Sinai published a massive breakthrough on this exact compound. They took 5-MeO-DMT and added that same Fluorine at the 4-position.

What it does: Just like with 4F-DMT, the Fluorine crushes the 5-HT2A hallucinogenic affinity (a 3-fold decrease).

But the real magic is that it creates a 14-fold increase in binding to the 5-HT1A receptor.

Why it matters: 5-HT1A is the golden receptor for deep, therapeutic antidepressant and anti-anxiety effects.

By creating 4F-5-MeO-DMT, scientists engineered a “non-hallucinogenic psychedelic”. You get all the massive, brain-healing, depression-curing benefits of toad venom, but without actually tripping or losing your mind. All the medicine, zero trip.

Conclusion

We are entering an era where psychedelics are being surgically engineered for specific real-world applications. Whether it's the clinical fast-track of 5F-MET, the social lubrication of 4F-DMT, or the trip-free healing of 4F-5-MeO-DMT, chemistry is wild.

TL;DR: Putting a Fluorine at the 4-position of a tryptamine stops it from binding to the receptor that causes visuals (5-HT2A). This turns 4F-DMT into a mild social empathogen ("diet MDMA"), and turns 4F-5-MeO-DMT into a trip-free, super-potent antidepressant that Big Pharma is heavily researching.

Sources and further reading :

https://medicalxpress.com/news/2024-05-scientists-unravel-psychedelic-drugs-interact.html

https://pubmed.ncbi.nlm.nih.gov/16061378/

https://pmc.ncbi.nlm.nih.gov/articles/PMC11152992/

https://www.sciencedirect.com/science/article/abs/pii/S0960894X05008735

https://pubs.acs.org/doi/10.1021/acsptsci.0c00176

Hey guys,

I’ve been seeing a lot of disappointed trip reports about the new 5F-MET hitting the RC scene lately, especially from people trying to take it orally or via nasal drops. I did some deep digging into recent pharmacological studies, and it turns out there’s a massive reason why it feels "weak" to us.

That "lab" testing it with robust IV results isn't some underground operation. 5F-MET is actually a billion-dollar pharmaceutical drug.

Its official scientific name is Bretisilocin (code name GM-2505). It was developed by Gilgamesh Pharmaceuticals—which recently got scooped up by the pharmaceutical giant AbbVie—specifically to treat Major Depressive Disorder. They are literally running Phase 2 clinical trials with it right now.

Here is exactly why the RC community is getting it wrong:

1. It was explicitly designed for IV only. Big Pharma knows exactly how tryptamines work. They chose intravenous (IV) infusion for their clinical trials because 5F-MET has absolutely garbage oral and nasal bioavailability. Just like base MET or DMT, if you swallow it or drip it down your nose, your stomach/liver enzymes (MAO) will destroy the molecule before it ever reaches your brain. If you're eating this stuff, you are quite literally flushing your stash down the toilet.

2. The reason behind the 5-Fluoro substitution. They didn't put a Fluorine at the 5-position to give us crazy, colorful visuals. They engineered it that way to tightly control the duration. By making it highly lipophilic (crossing the blood-brain barrier fast) but short-acting, they created a psychedelic that peaks and drops off quickly. The clinical goal is for a depressed patient to walk into a clinic, get an IV, trip balls for therapy, and go home 1 or 2 hours later, without tying up a hospital bed for 6+ hours like they would with psilocybin.

3. What this means for us. This isn't a bunk or weak chem; it's just a highly specialized clinical tool. Because of the first-pass metabolism, eating it or snorting liquid drops won't work. Unless you plan to IV (which obviously brings huge risks outside a hospital), your only real options to get those "robust" effects are probably boofing it, or vaping it if you can get it in freebase form.

TL;DR: 5F-MET is a legit Big Pharma drug called Bretisilocin made for quick, intense IV therapy sessions. Your stomach enzymes will destroy it if you eat it or do nasal drops. Don't waste your money eating it—boof it or vape it (if freebase) if you actually want to feel it.

https://news.abbvie.com/2025-08-25-AbbVie-to-Acquire-Gilgamesh-Pharmaceuticals-Bretisilocin,-a-Novel,-Investigational-Therapy-for-Major-Depressive-Disorder,-Expanding-Psychiatry-Pipeline

https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/a-phase-2a-study-of-two-repeated-doses-of-gm-2505-at-a-2-week-interval-in-patients-with-mdd/

https://www.clinicaltrialsarena.com/news/gilgamesh-psychedelic-high-remission-depression/